MedPath
HSA Approval

CELENID TABLET 25 mg

SIN06513P

CELENID TABLET 25 mg

CELENID TABLET 25 mg

August 21, 1991

MEDISPEC RENAISSANCE PTE. LTD.

MEDISPEC RENAISSANCE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDISPEC RENAISSANCE PTE. LTD.
Licence HolderMEDISPEC RENAISSANCE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N07CA02

cinnarizine

Manufacturer Information

MEDISPEC RENAISSANCE PTE. LTD.

BIOLAB CO LTD

Active Ingredients

CINNARIZINE

25 mg

Cinnarizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CELENID TABLET 25 mg - HSA Approval | MedPath